Publications by authors named "Emeline Bollaert"

Claim this Profile
contributes to cellular proliferation and survival in chronic myeloid leukemia and its inhibition enhances imatinib efficacy.
Joanne Peters, Emeline Bollaert, Anne-Sophie Cloos, Melissa Claus, Ahmed Essaghir

Noncoding RNA Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXO1 forkhead domain mutants in B-cell lymphoma lack transcriptional activity.
Ariane Sablon, Emeline Bollaert, Constance Pirson, Amélie I Velghe, Jean-Baptiste Demoulin

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin.
Emeline Bollaert, Melissa Claus, Virginie Vandewalle, Sandrine Lenglez, Ahmed Essaghir

Int J Mol Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2.
Virginie Vandewalle, Ahmed Essaghir, Emeline Bollaert, Sandrine Lenglez, Carlos Graux

J Cell Mol Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways.
Emeline Bollaert, Audrey de Rocca Serra, Jean-Baptiste Demoulin

Cell Mol Life Sci· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBP1 phosphorylation by AKT regulates its transcriptional activity and glioblastoma cell proliferation.
Emeline Bollaert, Manuel Johanns, Gaëtan Herinckx, Audrey de Rocca Serra, Virginie A Vandewalle

Cell Signal· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline /P16INK4A mutations contribute to genetic determinism of sarcoma.
Fanélie Jouenne, Isaure Chauvot de Beauchene, Emeline Bollaert, Marie-Françoise Avril, Olivier Caron

J Med Genet· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway.
Alexandra Coomans de Brachène, Emeline Bollaert, Astrid Eijkelenboom, Audrey de Rocca Serra, Kristan E van der Vos

Biochem J· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis